Table 2.
Empiric and Definitive Intravenous Therapy
| Empiric Therapy | Definitive Therapy | |||||
|---|---|---|---|---|---|---|
| Period 1 (n = 371) | Period 2 (n = 87) | Period 3 (n = 121) | Period 1 (n = 371) | Period 2 (n = 87) | Period 3 (n = 121) | |
| Vancomycin, No. (%) | 331 (89) | 75 (86) | 94 (78) | 143 (39) | 38 (44) | 29 (24) |
| Daptomycin, No. (%) | 16 (4.3) | 1 (1.1) | 10 (8.3) | 19 (5.1) | 4 (4.6) | 8 (6.6) |
| Oxacillin, No. (%) | 2 (0.54) | 0 (0) | 0 (0) | 50 (13) | 4 (4.6) | 26 (21) |
| Cefazolin, No. (%) | 1 (0.27) | 2 (2.3) | 0 (0) | 127 (34) | 34 (39) | 45 (37) |
| Other,a No. (%) | 17 (4.6) | 7 (8.0) | 17 (14) | 23 (6.2) | 5 (5.7) | 13 (11) |
| None, No. (%) | 4 (1.1) | 2 (2.3) | 0 (0) | 9 (2.4) | 2 (2.3) | 0 (0) |
aOther agents included cefepime, ceftriaxone, clindamycin, doxycycline, ertapenem, levofloxacin, linezolid, meropenem, piperacillin/tazobactam, and telavancin.